Antibacterial activity of plant-extract mediated silver nanoparticles against Klebsiella spp. in Africa: a systematic review

植物提取物介导的银纳米粒子对非洲克雷伯氏菌属的抗菌活性:系统综述

阅读:1

Abstract

INTRODUCTION: Antimicrobial resistance (AMR) among Klebsiella spp. is an escalating global health concern, particularly in resource-limited settings. The rapid spread of multidrug-resistant strains has rendered conventional antibiotics increasingly ineffective. In Africa, the green synthesis of silver nanoparticles (AgNPs) using medicinal plant extracts offers a sustainable and cost-effective approach for developing novel antibacterial agents. METHODS: This systematic review followed PRISMA 2020 guidelines. A comprehensive search was conducted across PubMed, Scopus, Web of Science, Google Scholar, and African Journals Online (AJOL) for studies published between January 2015 and May 2025. Eligible studies included in vitro experiments evaluating the antibacterial activity of plant extract-mediated AgNPs against Klebsiella spp. Two reviewers independently screened articles, extracted data, and assessed quality using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for in vitro studies. RESULTS: Out of 323 identified records, 14 studies met the inclusion criteria. The studies originated from Egypt (n = 4), Nigeria (n = 4), Kenya (n = 3), South Africa (n = 2), Tunisia (n = 1), and Ghana (n = 1). Frequently used plant species included Azadirachta indica, Moringa oleifera, Vernonia amygdalina, Allium sativum, Carica papaya, and Ocimum gratissimum. Silver nanoparticles synthesized from these extracts were typically spherical and measured 20-100 nm in diameter. All studies reported significant in vitro antibacterial activity, with zones of inhibition ranging from 10 to 24 mm and minimum inhibitory concentrations (MICs) ranging from 6.25 to 50 μg/mL. CONCLUSION: Plant-mediated silver nanoparticles exhibit strong in vitro efficacy against Klebsiella spp., supporting their potential role as alternative or adjunct antimicrobial agents in managing AMR. However, further in vivo studies, toxicological assessments, and standardization of nanoparticle synthesis and testing protocols are essential for their translation into clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。